Valuation: Alfresa Holdings Corporation

Market Cap 410B 2.58B 2.21B 2.07B 1.89B 3.55B 247B 3.6B 24.42B 9.52B 124B 9.68B 9.47B P/E 2027 *
17.8x
P/E 2028 * 14.8x
Enterprise Value 410B 2.58B 2.21B 2.07B 1.89B 3.55B 247B 3.6B 24.42B 9.52B 124B 9.68B 9.47B EV / Sales 2027 *
0.13x
EV / Sales 2028 * 0.12x
Free-Float
88.35%
Yield 2027 *
3.04%
Yield 2028 * 3.38%
Jun. 30 Ember LifeSciences, Inc. announced that it has received funding from Alfresa Holdings Corporation CI
Jun. 21 Alfresa Holdings Corporation(TSE:2784) dropped from S&P Japan Mid Cap 100 CI
May. 26 ReeNT Co., Ltd. announced that it expects to receive ¥600 million in funding from Alfresa Holdings Corporation CI
May. 26 Alfresa Holdings Corporation concluded a share transfer agreement to acquire Nagashima Medical Instruments Co., Ltd. from Nagashima Holdings Co., Ltd. CI
May. 18 Alfresa Holdings Corporation's Equity Buyback announced on May 15, 2026, has closed with 6,307,800 shares, representing 3.47% for ¥14,999.95 million. CI
May. 18 Tranche Update on Alfresa Holdings Corporation's Equity Buyback Plan announced on May 15, 2026. CI
May. 15 Alfresa Holdings Corporation authorizes a Buyback Plan. CI
May. 15 Alfresa Holdings Corporation announces an Equity Buyback for 6,307,800 shares, representing 3.46% for ¥14,999.95 million. CI
May. 15 Alfresa Holdings Corp - to buy back up to 3.5% of own shares worth about 15 billion yen RE
May. 15 Alfresa Holdings Corporation Announces Cash Dividend for the Year-End of the Fiscal Year Ended March 31, 2026, Payable on June 2, 2026; Provides Cash Dividend Guidance for the Second Quarter-End and Year-End of the Fiscal Year Ending March 31, 2027 CI
May. 15 Alfresa Holdings Corporation Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2026 and for the Fiscal Year Ending March 31, 2027 CI
Apr. 07 Healios Secures 144 Million Yen Initial Order from Alfresa's Korean Unit for Cosmetic Raw Material MT
Feb. 26 Alfresa Holdings Corporation concluded a share transfer agreement to acquire Techno Suzuta, Co.,Ltd. from Onsendo, K.K. CI
1 day+0.73%
1 week+4.75%
Current month+0.75%
1 month+0.78%
3 months+5.25%
6 months-7.72%
Current year-3.87%
1 week 2,245
Extreme 2245
2,351
1 month 2,131.5
Extreme 2131.5
2,475
Current year 2,106.5
Extreme 2106.5
2,685.5
1 year 2,055
Extreme 2055
2,685.5
3 years 1,897
Extreme 1897
2,685.5
5 years 1,505
Extreme 1505
2,685.5
10 years 1,505
Extreme 1505
3,350
Manager TitleAgeSince
Chief Executive Officer 63 -
Chief Tech/Sci/R&D Officer 63 2022-06-27
Corporate Officer/Principal 61 2020-03-31
Director TitleAgeSince
Director/Board Member 63 2007-05-31
Director/Board Member 65 2025-06-24
Director/Board Member 50 2020-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.73%+4.75%+3.73%-3.23% 2.56B
+1.95%+4.59%-11.85%+12.02% 198B
+0.83%+2.10%+2.29%+14.19% 118B
+0.88%+1.32%+4.86%+75.70% 60.05B
-1.37%-6.27%+28.79%+60.98% 53.18B
+1.79%+4.26%-2.75%-30.62% 51.11B
+1.81%+2.31%+13.89%-12.29% 34.05B
+4.08%-4.87% - - 28.58B
-0.09%+1.27%+45.84%-9.89% 24.9B
+0.82%+1.89%-3.97%+6.70% 22.98B
Average +1.14%+0.06%+8.98%+12.62% 59.31B
Weighted average by Cap. +1.25%+0.84%+2.03%+17.28%

Financials

2027 *2028 *
Net sales 3,189B 20.06B 17.18B 16.08B 14.72B 27.62B 1,919B 27.98B 190B 74.07B 964B 75.31B 73.67B 3,280B 20.63B 17.67B 16.53B 15.14B 28.4B 1,974B 28.78B 195B 76.18B 992B 77.46B 75.78B
Net income 23.49B 148M 127M 118M 108M 203M 14.13B 206M 1.4B 546M 7.1B 555M 543M 27.35B 172M 147M 138M 126M 237M 16.46B 240M 1.63B 635M 8.27B 646M 632M
Net Debt - -
Logo Alfresa Holdings Corporation
Alfresa Holdings Corporation is a Japan-based holding company primarily engaged in the wholesale of drugs. The Company operates in four business segments. The Pharmaceutical Wholesale segment is engaged in the wholesale of medical products, test reagents, as well as medical equipment and materials. The Self Medication Wholesale segment is engaged in the wholesale of general drugs. The Pharmaceutical Manufacture segment is engaged in the manufacture and sale of pharmaceuticals, test reagents, medical equipment and implements, as well as pharmaceutical powders. The Medical-Related segment is mainly engaged in operation of pharmacies. The others business is engaged in the information system business, the transportation business, the warehousing business, the insurance agency business, the real estate management business, the sale of miscellaneous goods, as well as the manpower dispatching business, among others.
Employees
12,525
Date Price Change Volume
26-08-21 ¥2,337.00 +0.73% 400,600
26-08-20 ¥2,320.00 +0.39% 310,000
26-08-19 ¥2,311.00 +0.96% 460,100
26-08-18 ¥2,289.00 +1.73% 645,100
26-08-17 ¥2,250.00 0.00% 342,300
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
2,337.00JPY
Average target price
2,340.00JPY
Spread / Average Target
+0.13%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2784 Stock